tirzepatide 16.7 MG/ML
RxNorm concept 2732441, clinical drug component (scdc).
- RxCUI
- 2732441
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2732441 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- tirzepatide 16.7 MG/ML Injectable Solution (SCD, constitutes)
- tirzepatide 16.7 MG/ML Injectable Solution [Zepbound] (SBD, constitutes)
- tirzepatide 16.7 MG/ML Injectable Solution [Mounjaro] (SBD, constitutes)
- 2.4 ML tirzepatide 16.7 MG/ML Pen Injector (SCD, constitutes)
- 2.4 ML tirzepatide 16.7 MG/ML Pen Injector [Zepbound] (SBD, constitutes)
- 2.4 ML tirzepatide 16.7 MG/ML Pen Injector [Mounjaro] (SBD, constitutes)
- tirzepatide (IN, has ingredient)
- tirzepatide 16.7 MG/ML [Zepbound] (SBDC, has tradename)
- tirzepatide 16.7 MG/ML [Mounjaro] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2732441 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2732441 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2732441. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.